RecruitingPhase 3NCT07037433
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Sponsor: Amgen
Jackson, MS · Tupelo, MS · +138 more sites
Obesity clinical trials in Tupelo, MS
1 recruiting obesity studies with a site in Tupelo, MS.
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.